Fundraising FoxCWRU Technology Ventures — Full Portfolio
41 tracked investments · listed companies and verified rows first
Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer.
BiotechDigital HealthHealthtechMedical DevicesLake Forest, US
Michael A Gordon(Executive Officer)inShaun O'Neil(Executive Officer)inLishan Aklog(Chairman & CEO)inBrian deGuzman(Chief Technology Officer & Chief Compliance Officer)inDennis M. McGrath(Chief Financial Officer)inShaun M. O'Neil(President and Chief Operating Officer)in
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.
BiotechDeep TechHealthtechMedical Devices
Harold Punnett(Co-founder)inJerry Silver(Co-founder)William Adams(Executive Officer)Paul Brennan(Director, Executive Officer)inDaniel Mikol(Executive Officer)inAdam Rogersin
Co-investorsSCI Ventures
Afference develops neurotechnology that enables remote sensory perception through wearable devices, allowing people at a distance to share tactile sensations.
AI & Machine LearningDeep TechHardwareHealthtechCleveland, US
Jacob Segil(Co-founder & CEO)inDustin Tyler(Co-founder & CTO)in
BoardTaylor Hurst(Director)inTrevor Zimmerman(Director)in
Co-investorsAnthropy PartnersEvolution VC PartnersHannah Grey VenturesJobsOhio VenturesKonvoy VenturesMighty Capital+6 more
AlensiaXR develops holographic technology that replaces traditional cadavers in medical and dental education.
Deep TechEdTechHealthtech
Mark Day(Chief Executive Officer)in
Co-investorsJobsOhio VenturesJumpstart Ventures
Atelerix Life Sciences develops novel respiratory therapies for drug-induced respiratory depression, respiratory disease exacerbations, and bio-defense against respiratory threats.
BiotechHealthtechMedical DevicesIndianapolis, US
David Kalergis(Executive Officer, Director, Promoter)William Akridge(Director)
BoardPeter Barton Hutt(Director)
Atomic Industries uses artificial intelligence and custom software to design plastic molds for manufacturing, enabling faster production of injection-molded parts for customers.
Advanced ManufacturingAI & Machine LearningRoboticsDetroit, US
Aaron Slodov(Founder)inAustin Bishop(Founder)Lou Young Jr.(Founder)
Co-investorsAcequia Capital (AceCap)Earthrise VenturesImpatient VenturesIn-Q-TelJulian CapitalMaC Venture Capital+16 more
.jpeg){kind=logo}
BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods.
BiotechHealthtechMedical DevicesCleveland, US
BIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations.
Digital HealthDirect to ConsumerWellness & FitnessCleveland, US
Mahmoud Ghannoum(Founder)inAfif Ghannoum(Director)inSam Schatz(Executive Officer)inMichael Haritakis(Executive Officer)inSteven Himmel(Director)
BoardBob Pavey(Director)
Co-investorsJobsOhio VenturesJumpstart VenturesMiddleland Capital
Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses.
BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US
George B. Rathmann(First CEO)
BoardWilliam K. Bowes
Co-investorsAsset Management CompanyBOMMayfield FundUS Venture PartnersYsios Capital
Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders.
BiotechHealthtech
BONEZONE is a media platform and conference brand serving orthopedic device manufacturers with editorial content, digital publications, and industry networking focused on product development, regulatory trends, and market intelligence.
Marketing TechMedia & EntertainmentMedical Devices
Convelo Therapeutics develops remyelination-enhancing therapies that target the central nervous system's myelination pathway to repair nerve damage in people with multiple sclerosis.
BiotechDeep TechHealthtechCleveland, US
Paul Tesar(Co-founder (Professor, PhD))inDrew Adams(Co-founder (Professor, PhD))inDerrick Rossi(Leader/Executive)inTracy Saxton(Chief Operating Officer)inEd Mok(Head of Finance)Samantha Stubblefield(VP of Operations and Business Development)in
Co-investorsJobsOhio VenturesJumpstart Ventures
COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease.
BiotechDeep TechHealthtechMedical DevicesCleveland, US
Edifice Analytics provides software that quantifies energy and cost savings opportunities in commercial buildings using diagnostics, prognostics, and comparative analytics.
CleantechData & InfrastructureEnterprise SoftwareCleveland, US
Alexis Abramson(Co-founder / Senior Technical Advisor)Roger French(Co-founder / CTO)Dave Gordon(CEO)in
Medtronic designs and develops medical technology for treating complex diseases.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investors8VCElevate VenturesMenlo VenturesOak Investment PartnersPfizer Venture InvestmentsQuesta Capital+5 more
Folio Photonics develops optical storage media using multi-layer read/write materials science to provide enterprise-scale, immutable active archive storage.
Data & InfrastructureDeep TechNew MaterialsSolon, US
Kenneth D. Singer(Executive Officer, Director)Steven J. Santamaria(Executive Officer, Director)inRonald B. Richard(Director)Robert D. Pavey(Director)Felix Brueck(Director)
Co-investorsJobsOhio VenturesMaterial ImpactRefinery VentureForte Ventures
Galvanix develops a proprietary sustainable metal reduction process for producing rare earth permanent magnets, addressing the environmental concerns of China-dominated production methods and enabling domestic manufacturing.
Advanced ManufacturingCleantechNew Materials
Alan Long(Co-founder)Rohan Akolkar(Co-founder)inLisa Ward(CEO)in
Global Health Metrics provides population health analytics and risk assessment tools for health plans, employers, and healthcare providers.
Data & InfrastructureEnterprise SoftwareHealthtech
Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders.
BiotechMedical Devices
Anirban Sen Gupta(CTO)Michael Bruckman(CEO)inMatthew Neal(CMO)Christa Pawlowski(COO and EVP of R&D)Timothy Pelura(Executive Chair)
Co-investorsTachyon Ventures
Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants.
Digital HealthHealthtechMedical DevicesPortland, US
Patricia White Seminario(Executive Officer, Director, Promoter)Peter Galen(Chief Innovation Officer, Co-Founder)inPatti White(Chief Executive Officer, Co-Founder)inDaren Bledsoe(Sr. VP, Engineering & Operations)inGerrit van Roekel(VP, Business Development)inUmut Gurkan(Chief Scientist, Microfluidics)in
Co-investorsElevate CapitalIdeashipImpact India Investment PartnersPortland Seed Fund
Light-Handed is developing diagnostic technology to improve the diagnosis of middle ear effusion (MEE), applying biomedical optics to medical device development.
Deep TechHardwareHealthtechMedical Devices
Steven Burns(Chief Executive Officer)inBrecken Blackburn(Chief Science Officer)inMatt McPheeters(Chief Technology Officer)in
Co-investorsJumpStart Equity
Luminary Therapeutics is a clinical-stage biotech developing allogeneic CAR-T cell therapies built on its Gamma 2.0+ platform to treat solid tumors, B-cell malignancies, and B-cell-mediated autoimmune diseases.
AI & Machine LearningBiotechHealthtechMinneapolis, US
David Largaespada(Executive Officer, Director, Promoter)Jeff Liter(Executive Officer, Director, Promoter)James Haymaker(Director, Promoter)
BoardJeff Ross(Director)John Wells(Director)Tracey Lodie(Director)
MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound.
BiotechHealthtechMedical DevicesOhio, US
Audrey Carballo
Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
BiotechHealthtechMedical DevicesWellington, US
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardJoyce Erony(Director)inWilliam Harrington(Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+6 more
Picture Health develops AI tools that analyze routine radiology and pathology images to quantify biological properties of tumors for precision oncology.
AI & Machine LearningBiotechHealthtech
Co-investorsCintrifuse CapitalJobsOhio VenturesRefinery Venture
Symphony Robotics develops investigational robotic technology for healthcare applications.
Medical DevicesRobotics
Mordechai (Moty) Avisar(Founder)in
Synapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS.
BiotechDigital HealthHealthtechMedical DevicesHarrisburg, US
Raymond P Onders(Director)Anthony R. Ignagni(Co-founder, President & CEO)Moustapha Diop(Chief Operating Officer)Kiyotaka Mori(Director)John Krystowski(Director)
Co-investorsJumpstart Ventures
Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy.
BiotechBoston, US
Harvey LodishDaniel Fischer(Co-Founder, President and CEO, Board Member)inWarren Lammert(Co-Founder and Chairman of the Board)inHarvey Lodish, Ph.D.(Co-Founder, Chair of the SAB, and Board Member)Jeffery Coller, Ph.D.(Scientific Co-Founder, Scientific Advisor)
Co-investorsGood Growth CapitalLauder Partners
Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research.
AI & Machine LearningBiotechDeep TechMedical DevicesBeachwood, US
Jan Jensen(Founder)inDivya Trivedi(Chief Operating Officer and Secretary)David Llewellyn(President & CEO)inJosh Snow(Chief Commercial Officer)inJennifer Antonchuk(Vice President of Research and Development)in
BoardMichael Kaufman(Director)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AnemedIntwine ConnectOpsiClearPolymerPlusPresidio MedicalRodeo TherapeuticsRora BiologicsSHC Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.